These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33593208)

  • 1. Giganteone A and malabaricone C as potential pharmacotherapy for diabetes mellitus.
    Sivasothy Y; Leong KH; Loo KY; Adbul Wahab SM; Othman MA; Awang K
    Nat Prod Res; 2022 Mar; 36(6):1581-1586. PubMed ID: 33593208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potent alpha-glucosidase inhibitor from Myristica cinnamomea King.
    Sivasothy Y; Loo KY; Leong KH; Litaudon M; Awang K
    Phytochemistry; 2016 Feb; 122():265-269. PubMed ID: 26712615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetic potential of phytochemicals isolated from the stem bark of Myristica fatua Houtt. var. magnifica (Bedd.) Sinclair.
    Prabha B; Neethu S; Krishnan SL; Sherin DR; Madhukrishnan M; Ananthakrishnan R; Rameshkumar KB; Manojkumar TK; Jayamurthy P; Radhakrishnan KV
    Bioorg Med Chem; 2018 Jul; 26(12):3461-3467. PubMed ID: 29789207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
    Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
    Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A trisaccharide phenylethanoid glycoside from Scrophularia flava Grau with potential anti-type 2 diabetic properties by inhibiting α-glucosidase enzyme and decreasing oxidative stress.
    Hamedi A; Pasdaran A; Pasdaran A
    Bioorg Chem; 2020 Jun; 99():103776. PubMed ID: 32276136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Furofuran lignans as a new series of antidiabetic agents exerting α-glucosidase inhibition and radical scarvenging: Semisynthesis, kinetic study and molecular modeling.
    Worawalai W; Doungwichitrkul T; Rangubpit W; Taweechat P; Sompornpisut P; Phuwapraisirisan P
    Bioorg Chem; 2019 Jun; 87():783-793. PubMed ID: 30978603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies.
    Wali S; Atia-Tul-Wahab ; Ullah S; Khan MA; Hussain S; Shaikh M; Atta-Ur-Rahman ; Choudhary MI
    Bioorg Chem; 2022 Feb; 119():105506. PubMed ID: 34896920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and docking of indole sulfonamide as a potent inhibitor of α-glucosidase enzyme in streptozotocin -induced diabetic albino wistar rats.
    Taha M; Imran S; Salahuddin M; Iqbal N; Rahim F; Uddin N; Shehzad A; Khalid Farooq R; Alomari M; Mohammed Khan K
    Bioorg Chem; 2021 May; 110():104808. PubMed ID: 33756236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis,Antidiabetic and Antitubercular Evaluation of Quinoline-pyrazolopyrimidine hybrids and Quinoline-4-Arylamines.
    Cele N; Awolade P; Seboletswe P; Khubone L; Olofinsan K; Islam MS; Jordaan A; Warner DF; Singh P
    ChemistryOpen; 2024 Sep; 13(9):e202400014. PubMed ID: 38506589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
    Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Antioxidant and Anti-α-glucosidase Activities of Various Solvent Extracts and Major Bioactive Components from the Seeds of
    Li CW; Chu YC; Huang CY; Fu SL; Chen JJ
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33171671
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis, in vitro α-glucosidase inhibitory activities, and molecular dynamic simulations of novel 4-hydroxyquinolinone-hydrazones as potential antidiabetic agents.
    Shayegan N; Haghipour S; Tanideh N; Moazzam A; Mojtabavi S; Faramarzi MA; Irajie C; Parizad S; Ansari S; Larijani B; Hosseini S; Iraji A; Mahdavi M
    Sci Rep; 2023 Apr; 13(1):6304. PubMed ID: 37072431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indole acrylonitriles as potential anti-hyperglycemic agents: Synthesis, α-glucosidase inhibitory activity and molecular docking studies.
    Solangi M; Kanwal ; Mohammed Khan K; Saleem F; Hameed S; Iqbal J; Shafique Z; Qureshi U; Ul-Haq Z; Taha M; Perveen S
    Bioorg Med Chem; 2020 Nov; 28(21):115605. PubMed ID: 33065441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of 3-styrylchromone derivatives as free radical scavengers and α-glucosidase inhibitors.
    Takao K; Ishikawa R; Sugita Y
    Chem Pharm Bull (Tokyo); 2014; 62(8):810-5. PubMed ID: 25087634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li X; Li J
    Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of new 2-phenyl-1H-benzo[d]imidazole core-based potent α-glucosidase inhibitors: Synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Li Y; Zhang JH; Xie HX; Ge YX; Wang KM; Song ZL; Zhu KK; Zhang J; Jiang CS
    Bioorg Chem; 2021 Dec; 117():105423. PubMed ID: 34717239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory evaluation of
    Zabidi NA; Ishak NA; Hamid M; Ashari SE; Mohammad Latif MA
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):109-121. PubMed ID: 33249946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug repurposing for diabetes mellitus: In silico and in vitro investigation of DrugBank database for α-glucosidase inhibitors.
    Sadeghi M; Miroliaei M; Ghanadian M
    Int J Biol Macromol; 2024 Jun; 270(Pt 1):132164. PubMed ID: 38729474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, α-glucosidase inhibitory activity and in silico study of tris-indole hybrid scaffold with oxadiazole ring: As potential leads for the management of type-II diabetes mellitus.
    Taha M; Rahim F; Imran S; Ismail NH; Ullah H; Selvaraj M; Javid MT; Salar U; Ali M; Khan KM
    Bioorg Chem; 2017 Oct; 74():30-40. PubMed ID: 28750203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of 1,3,4-oxadiazolyl-containing β-carboline derivatives as novel α-glucosidase inhibitors with antidiabetic activity.
    Xiao D; Lu L; Liang B; Xiong Z; Xu X; Chen WH
    Eur J Med Chem; 2023 Dec; 261():115795. PubMed ID: 37688939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.